Introduction
Diamond is a material with extreme physical, chemical and electrical properties [1] , it is inert [2] , robust and has high longevity. Nanocrystalline diamond (NCD) films produced by chemical vapour deposition (CVD) display very similar properties [3] . The passive chemical nature and the desirable tuneable electrical properties of diamond, including its wide electrochemical window, make it a highly desirable material for many bio-applications, specifically for interfacing with electrical cells as electrodes. The main hindrance of using planar films of diamond as an electrode material is the relatively low capacitance values obtained; an ideal electrode material has a high capacitance and this can be increased in diamond by increasing the surface area of the electrode. This has been achieved via seeding nanodiamonds on carbon nanotubes (CNTs) [4] and thus nanostructuring the diamond films, such films have shown excellent electrical properties. Here, these substrates have been investigated to see if the inclusion of boron and the effect of increased surface area via the nanostructuring has any observable outcome on the biocompatibility of the diamond.
The superlative electrical properties of boron-doped diamond (BDD) make it a desired material of choice for many neural interface applications. BDD can be either p-type [5] [6] [7] in character or quasi-metallic at high boron concentrations (>10 20 cm −3 ) [8] [9] [10] . In its quasi-metallic state it is a desirable choice of material for bio-electrochemical electrodes due to its chemical inertness [11] , high structural stability at desired current charge densities [12] and low background current [13, 14] compared to metal electrodes [15] , both in vivo [16] and in vitro [17] . Moreover, the so-called electrochemical window of BDD electrodes, the voltage that can be applied before the onset of unwanted water redox reactions, is considerably higher than electrodes made for metals or other forms of carbon [18] . Boron doped nanocrystalline diamond (BNCD) has also been used for biosensing, with H-terminated BNCD being used for the sensing of DNA [19, 20] and glucose [21] , and O-terminated BNCD for sensing dopamine [22] and uric acid [23] . BNCD has been used material of choice for the fabrication of diamond microelectrode arrays (MEAs) [24] [25] [26] [27] , in particular Piret et al fabricated 3D-nanostructured BNCD MEAs with low level detection of neural activity, electrodes had a wide potential window and storage capacitance of 10 mC cm −2 [28] . BNCD is also a highly desirable material for neural prostheses and neural interfaces [29] [30] [31] , as well as being used as a successful electrode material for neural stimulation [32] .
For a material to be successful as a neural interface, it has to be both electrically active and biocompatible. The biocompatibility of un-doped CVD diamond, including NCD, has been investigated by cell viability and protein absorption methods, with most studies indicating that diamond is highly biocompatible [33] [34] [35] . BDD offers properties required for many cell interfacing applications, including the recording of action potentials from electrogenic cells [27] . To date, the biocompatibility of BNCD materials, where the boron concentration is as high as 10 21 cm −3 has not been explored, that is the subject of the current paper. Of particular note is the use of vertically aligned CNTs (VACNTs) attached to substrates and subsequently overgrown with BNCD. This leads to a 3D structured BNCD material that can act as a scaffold for cellular attachment and outgrowth, and the biocompatibility of these novel 3D structures has also been explored. Planar thin films of BNCD can suffer from a relatively low double layer capacitance, and high impedance, reducing such electrodes performance for cell stimulation despite the attractive biocompatibility. 3D nanostructuring offers the prospect of overcoming this limitation, offering an innovative approach for electronic material-cellular interfacing.
The biocompatibility of diamond initiated a lot of work in which cells are grown on diamond, first reports of this occurred in 2004 by Specht et al [36] ; where neurons were successfully grown on single crystal diamond, and since then, numerous reports have shown NCD positively supporting the adhesion and proliferation of many cell lines including osteoblasts [37] [38] [39] , fibroblasts [40] and mesenchymal stem cells [41] . Patterned NCD films and nanodiamond layers have also been shown to direct neural adhesion and neurite outgrowth [34, 42, 43] . Here, the degree of human-neural stem cell (hNSC) adhesion and proliferation on diamond materials with these extreme levels of boron incorporation has been investigated via live cell staining using 5-chloromethylfluorescein diacetate (CMFDA); a live cell fluorescent marker, along with the use of a methylene blue assay. HNSCs have been used for this biocompatibility study due to their sensitivity and highly responsive behaviour to external stimuli; this is in contrast to robust cancerous cells.
Methods

NCD and BNCD growth
NCD films were grown on silicon substrates. Prior to growth the Si substrates were seeded with diamond nanoparticles by spin coating. high pressure high temperature diamond nanoparticles with diameter approximately 25 nm (0.1% wt/wt, SYP GAF 0-0.05, Van Moppes) were dispersed in water (0.1 wt%). The substrates were seeded by spin coating (2000 rpm for 20 s) and dried in N 2 gas (as previously reported by Girard et al) [44] . NCD was grown in an AX6500X microwave plasma enhanced chemical vapour deposition system (Seki Technotron Corp.). The growth was performed for 10 h using the following parameters: MW power of 2.6 kW, pressure of 26 mbar, temperature of 650°C, H 2 flow of 400 sccm, CH 4 flow of 4 sccm. BNCD films were grown using these same growth parameters except trimethylborane (TMB, B(CH 3 ) 3 ) was added to the gas phase (2.4% TMB in CH 4 ). Such conditions lead to BNCD with a boron concentration of ca. 2×10 21 cm −3 , as described by Vanhove et al [13] . NCD and BNCD surfaces were oxygenated using an ozone treatment (50 mbar) for two hours, at 200°C.
Fabrication of BNCD coated CNTs
VACNTs were deposited onto BNCD layers, prepared as described above. First, a 7 nm nickel layer was deposited on the diamond surface by e-beam evaporation and the sintered into ∼50 nm nanoparticles by heating at 700°C for 3 min The samples were then transferred into a plasma enhanced CVD reactor, ('Black Magic' AIXTRON) whereby the sintered nickel particles act as the catalyst site in which VACNTs are grown. CNTs of differing length were deposited by varying growth times; 1 μm and 2 μm for growths of 5 and 11 min respectively. The VACNTs were then coated with NDs via an electrostatic grafting method described by Girard et al [44] . This step transforms the VACNTs into bundles of CNTs with densities of 9 and 4 bundles μm −2 for CNTs of length 1 μm and 2 μm respectively. Finally, BNCD was grown in a MWPECVD (AX6500X) reactor until a BNCD thin film coating of ∼50 nm was obtained upon the bundles. Boron incorporation was also optimised up to a boron concentration of 2×10 21 cm −3 such that the films became highly electrically conductive [4] . BNCD coated CNT surfaces were oxygenated using an ozone treatment as described above.
Atomic force microscopy (AFM)
AFM measurements were carried out using a Veeco Dimension V instrument with aluminum-coated silicon AFM probes (resonant frequency 190 kHz). The system was operated in tapping mode with a VT-103-3K acoustic/vibration isolation system and a VT-102 vibration isolation table at room temperature in air. AFM was performed on tissue culture polystyrene (TCPS) and on NCD and BNCD films. Scan sizes of 2 μm for the TCPS and 5 μm for the NCD and BNCD films were taken and an arithmetic average of the roughness profile (R a ) was calculated using Nanoscope Software 6.1.3. AFM Images were post processed with a median filter (3×3 kernel) using MATLAB 2012a software to remove noise and measurement artifacts.
Scanning electron microscopy (SEM).
The BNCD covered CNT bundles were characterized using a Carl Zeiss XB1540 focused-ion-beam microscope with an accelerating voltage of 5 kV, these images were used to calculate bundle density.
HNSCs isolation and culture.
All procedures involving human tissue were carried out in accordance with the UK Human Tissue Act 2006. The hNSCs were isolated and expanded according to the protocol described previously by Sun et al [45] . Briefly, hindbrains from human embryos between 6-10 weeks old were collected through Human Developmental Biology Resource and dissected in cold Neurobasal medium (Gibco). After complete removal of the meninges and blood vessels, the tissue was chopped into smaller pieces and digested in Accutase (Gibco) solution at 37°C for 30 min with occasional trituration to obtain single cell suspension. Cells were then centrifuged and resuspended in growth medium composed of DMEM/F12 with Glutamax supplemented with 1% (v/v) Penicillin/Streptomycin, 1% (v/v) 100×N2 supplement, 2% (v/v) 50×B27 supplement (all Gibco), 20 ng ml −1 human recombinant FGF2, 20 ng ml −1 human recombinant EGF (both Peprotech), 50 μg ml −1 BSA fraction V and 5 μg ml −1 Heparin (both Sigma). Cells were plated on polylysine/laminin (10 μg ml −1 , Sigma)-coated dishes and grown for 7 days in vitro with the media changed every 2 days to remove any dead cells or debris. To eliminate neurons from the primary cultures and get a homogenous culture of neural stem cells, the cells were first transferred onto 0.1% (w/v) bovine gelatine (Sigma)-coated dishes for 7 days to form neurospheres, which were then re-plated onto laminin-coated dishes for further expansion. For routine expansion and further experiments, cells were grown in growth media supplemented with laminin instead of coating the dishes. Passages up to 30 were used for all experiments.
2.5.1. Immunocytochemistry characterisation of hNSCs. For immunocytochemistry hNSCs were seeded either on polylysine/laminin coated glass cover slips or eight well imaging chamber slides (PAA). The cells were fixed with 4% (w/v) paraformaldehyde (PFA) solution in PBS, pH=7.4 for 15 min at RT. After three rinses with PBS the cells were incubated with blocking solution composed of 10% (v/v) FBS, 3% (w/v) BSA in PBS with 0.2% (v/v) TritonX-100 for 1 h at RT to permeabilize cell membranes. Primary and secondary antibodies were diluted in blocking solution and the incubation times were overnight at 4°C for primary, and 1 h at RT for secondary antibodies. Hoechst 33258 (2 μg ml −1 ) was added during secondary antibody incubation to counterstain cell nuclei. After final three washes in PBS the coverslips were mounted on slides with an aqueous based mounting medium (Hydromount, National Diagnostics). Primary and secondary antibodies used can be seen in the table 1.
2.5.2. Induced hNSC differentiation. The controlled differentiation of hNSCs into astrocytes, oligodendrocytes and neurons has been adapted from Sun et al's protocol, as described in [45] .
To induce astrocytic differentiation of hNSCs, the cells were cultured in media composed of DMEM/F12 medium, supplemented with 1% Penicillin/Streptomycin and 10% FBS for 2 weeks.
For neuronal differentiation hNSC were plated on laminin-coated plates in expansion medium without EGF supplement to induce differentiation. After 10 days in culture, FGF2 and heparin were also withdrawn from the media for another 4 days. Finally, neuron maturation was then induced by culturing in Neurobasal A medium supplemented with 1% Penicillin/Streptomycin, 1% L-Glutamine, 2% B27 and 10 ng ml −1 human recombinant βNGF with 10 ng ml −1 human recombinant BDNF (both Peprotech) for another 2 weeks.
For oligodendrocytic differentiation cells were plated on laminin coated plates. The next day, the medium was changed to DMEM/F12 supplemented with 1% Penicillin/Streptomycin, 1% N2 supplement, 10nM forskolin, 10 ng ml −1 FGF2 and 10 ng ml −1 PDGFaa (Peprotech) for 14 days. On day 15 the medium was switched to DMEM/F12 supplemented with 1% Penicillin/Streptomycin, 1% N2 supplement, 30 ng ml −1 tri-iodothyronine (T3), 200 μM ascorbic acid and 10 ng ml −1 PDGFaa. After another 7 days, PDGFaa was withdrawn from the culture media to allow maturation of cells. hNSC isolation, confirmation and differentiation potential extremely important as it allows for the development of cell based therapies to continue [46] .
Cell attachment and morphology assay
Prior to cell seeding, substrates were treated with ozone in a vacuum chamber for 30 min, (200°C, 50 mbar) in order to increase homogeneity of surface chemistry between samples. Substrates were then placed in 24 well tissue culture plates, sterilized for 30 min in 70% ethanol and washed three times in sterile distilled water. hNSCs were then plated at a density of 3×10 4 cells cm −2 . Subconfluent hNSCs were labelled with the vital cytoplasmic dye, CMFDA (CMFDA, Cell Tracker, Invitrogen) in supplement-free culture media at 5 μM final concentration for 30 min. After the incubation, the cells were washed twice with phosphate buffer solution PBS, trypsinized and then plated on the different surfaces in the standard expansion media with laminin at a density of 3×10 4 cells cm −2 . Cell attachment and morphology were assessed after 24 h using an Olympus IX70 inverted fluorescent microscope for one sample per substrate type. For each sample, six randomly selected areas were imaged using monochromatic Hamamatsu-OrcaR2 camera/HCImage software at ×10 and ×40 magnification.
For actin staining hNSCs were fixed after 48 h in vitro in 4% (w/v) PFA in PBS (pH7.4) for 15 min and washed three times with PBS. Substrates were then incubated in blocking solution (10% fetal bovine serum, 3% bovine serum albumin in PBS with 0.2% Triton ×100 for permeablization) for 30 min at room temperature. Cells were stained with Phalloidin conjugated with Alexa Fluor ® 488 diluted in blocking buffer (Invitrogen, 5 U ml −1 ) together with Hoechst 33258 (2 μg ml −1 ) to counterstain nuclei for 1 h at room temperature. After three washes with PBS to remove excess dye the samples were imaged using an inverted microscope Olympus IX71 (Carl Zeiss, Jena, Germany) equipped with a Hamamatsu ORCA-ER digital camera (Hamamatsu Corp., Bridgewater, NJ) and image processing was done using Image J and Fiji.
Culture confluence for both Phalloidin and CMFDA stained images were calculated in Matlab R2012b by applying an intensity threshold to the stained images and taking the average of the percentage area of each image above threshold (at least six images at varying magnification for one sample per substrate). Intensity thresholds were selected for each image by calculating the intensity level corresponding to the minimum value of the derivative of the intensity histogram of each image. This corresponded to the intensity boundary between the background and the cells. A 0.03 factor was added to this factor to improve mapping precision. Confluency was displayed using box plots, (figures 3(b) and 4(b)) Cell counts were obtained for the Hoechst stained images in Matlab R2012b by applying an intensity threshold to the stained images and then using a find circular Hough transform to find the number of labelled nuclei per image, which was then scaled up accordingly (at least six images at varying magnification for one sample per substrate).
Methylene blue assay (MB)
Cell viability of hNSCs was assessed by the methylene blue assay, which is a spectrophotochemically quantitative method for obtaining healthy cell counts [47] . Cell viability has been compared on NCD and BNCD using TCPS as the control throughout. hNSCs were plated on sterilized samples (three samples per substrate) in 48 well plates, at a density of 3×10 4 cells cm −2 . After 48 h in culture cells were fixed in 4% (w/v) PFA in PBS (pH 7.4) for 15 min, washed once with PBS and incubated with 1% (w/v) methylene blue in 0.01 M borate buffer (pH 8.5) solution at room temperature for 30 min. Excess methylene blue in each well was washed off with 0.01 M borate buffer. The samples were then transferred to new wells and the dye was eluted in 1:1 (v/v) ethanol and 0.1 M HCI. The plates were gently shaken, then 100 μl of solution from each well were transferred to a 96 well plate and the absorbance was measured at 650 nm by a spectrophotometer (Revelation v4.21 Dynex Technologies). The absorbance measurements were then normalized to the surface area of the samples and compared to cells grown in standard TCPS. Figure 1 shows the surface topography of substrates used throughout this investigation. Figure 1(a) shows AFM images of NCD, BNCD and TCPS substrates accompanied by the root mean square roughness for each substrate. The roughness of the NCD and BNCD is much greater than that of the TCPS, (being 85 nm and 38 nm respectively, versus 3 nm). SEM has been used to show the structure of the BNCD CNT bundles, and figure 1(b) shows how the difference in length of the CNT alters the density of the bundles formed on the substrate. For CNTs of 1 μm length, the concentration of bundles is 9 μm −2 and for 2 μm long CNTs this decreases to an average of ca. 4 μm −2 .
Results
Substrate characterization
Characterisation of the isolated hNSCs
hNSCs have been isolated from human embryos aged between 6-10 weeks. Characterisation and confirmation of these cells has been summarized in figure 2 , shows both the isolated hNSCs and the differentiation potential of cells from the same isolated batch. hNSCs have been successfully differentiated into neurons, astrocytes and oligodendrocytes, hereby proving the classification of the cells. Numerous NSC fluorescent markers have been used to clarify the identity of the isolated cells, including Nestin, GFAP, SOX2, Vimentin, TUBB3 and BLBP, and stained images expressing these proteins are shown in figure 2(a) .
Survival of hNSC on NCD, BNCD and 3D nanostructured BNCD
hNSCs were seeded onto ozone-treated NCD; BNCD; BNCD-coated CNTs of length 1 μm and 2 μm; and TCPS, which was used as a control throughout. Cell attachment and morphology were assessed after 24 h in vitro using CMFDA, after 48 h via immunostaining using Phalloidin and Hoechst, and the methylene blue assay was used to evaluate cell viability on each substrate. First of all the viability of hNSCs on planar substrates without CNT nanostructuring was investigated using immunohistochemical imaging. Fluorescent stained images in figure 3(a) show Phalloidin-labelled actin in green and nuclei stained by Hoechst in blue. The images are optically very similar and confluency percentage ( figure 3(b) ) shows that there is no statistical difference between the TCPS control, NCD and BNCD (37.6±4.8%, 37.2±6.4%, 37.1±8.7% respectively). Furthermore, no discernable differences were apparent in the morphology of adherent cells across each planar substrate. These similar confluency percentages and uniform cell morphology indicate that both NCD and BNCD are as good as the control for hNSC adhesion. Cell count data ( figure 3(c) ) for TCPS, NCD and BNCD substrates also confirms the similarity of hNSC adherence with cell counts (2.33×10 5 cells cm −2 , 1.85×10 5 cells cm −2 , and 2.09×10 5 cells cm −2 respectively). Having established there to be no significant differences in hNSC viability between different substrate materials, cell viability was assessed for hNSC cultures upon CNT nanostructured substrates in comparison to planar substrates using live-cell staining and image analysis. CMFDA stained images in (figures 4(a) and (c)) show that the hNSCs have attached onto all surfaces, with a high confluence percentage and no indication of neurosphere formation, which can be indicative of hNSCs having poor adhesion to a biomaterial [48] . Further evidence of healthy attachment is demonstrated by the early formation of neurite processes after 24 h in vitro (figures 4(a) and (c) 2nd columns). The similar sub-confluent attachment (20-50% mean confluence) of hNSCs over all substrates show that the cells are proliferating at similar rates. No significant change in confluence is observed between CNT BNCD substrates and the TCPSb control. In terms of the cells conforming to the BNCD-CNT structures, the grouping of cells is ascribed to fasciculation, rather than 3D structure obstruction, because the scale of fasciculation voids being considerably larger than the density of the 3D structures for both substrates ( figure 4(b) ), 1 μm CNT BNCD: 9 bundles μm The MB assay is a semi-quantitative method for indicating the relative number of healthy cells there are per substrate. Figure 5 (a) MB assays reveal a slightly reduced cell count on NCD and BNCD samples in comparison to the TCPSa control. Error bars show standard deviation of the absorbance for each sample set (four substrates per sample), the larger error bars shown for NCD and BNCD result from using irregular sized substrates and so area calculations were not exact. Despite this, the cell counts for both NCD and BNCD are less than the TCPSa control. However, figure 5(b) shows very comparable cell counts between NCD and BNCD substrates, showing hNSCs to have a similar viability and propensity to attach and proliferate to NCD and BNCD surfaces. The nanostructured CNT BNCD samples showed significantly increased attachment of hNSCs in comparison to the TCPSb control, and moreover an increased cell count with increasing CNT length/reduced 3D structure density, (1 μm CNT 1.35 a.u., 2 μm CNT 1.55 a.u., TCPSb 1.1 a.u.) was observed.
Discussion
Nanoscale topography has been shown to influence neuronal adhesion upon diamond [49] , whereby surfaces with features of higher curvature promote neuronal adhesion. In NCD films curvature manifests in the size of grain boundaries, which in turn determines the roughness of substrates. The inclusion of boron in the diamond lattice during MWPECVD growth causes increased re-nucleation, resulting in smaller grains with higher curvature within BNCD materials, unlike intrinsic NCD materials which evolve larger grains during growth. In this case the reduced grain sizes of BNCD in comparison to NCD are still in excess of the dimensions that are conducive to nanotopographical enhancement of cellular adhesion ( figure 1(a) ). The similar values obtained from the MB assays for NCD and BNCD substrates (figures 5(a) and (b)) and the similar morphology of cells show the inclusion of boron within the diamond lattice not to be detrimental to hNSC adhesion, and that the reduced grain size of BNCD does not effect hNSC adhesion. The cell counts recorded here are comparable to murine NSCs grown on oxygenated ultrananocrystalline diamond [29] . Furthermore, the observation Upon 3D nanostructuring of BNCD substrates, the increased MB assay value of the CNT BNCD samples with respect to the TCPSb control substrate suggests nanostructuring enhances cell proliferation. Such an effect could be due to the increased surface area or enhanced local curvature of substrates. Given the monotonic increase in MB assay with respect to the length of CNTs, and the corresponding increase in sample surface area, this aspect of the substrate morphology could be ascribed to increasing cell proliferation. However, it has been shown [50] that cardiomyocytes cells preferentially sit atop of nanopillar features when spaced at a pitch of 2 μm spacing. Herein, the spacing of the 3D structures is less than 2 μm ( figure 1(b) ), hence, assuming hNSCs are of comparable size to cardiomyocyte cells, they are expected to be residing on top of the structures, thus surface area should not directly dictate cell count.
Concluding remarks
It has been found that the inclusion of boron in diamond has no observable effect of the proliferation and adherence of hNSCs. These results have been shown using image analysis of hNSCs grown on NCD and BNCD with TCPS as the control. Percentage confluency and cell count/MB data suggest that there is minimal difference between all three planar substrates. This significant result indicates that heavily BDD, which is required when diamond must be an electrical conductor, can be considered just as biocompatible as un-doped diamond. That this is even the case when such 'fragile' cells as hNSCs are used is encouraging for the use of, for example, 3D structured conductive diamond electrodes for several applications including deep brain and retinal implants. In addition to the assessment of BNCD versus NCD versus TCPS biocompatibility towards hNSCs, the impact of nanostructuring the BNCD using CNTs as scaffolds upon hNSC adherence and proliferation has been investigated. Herein it has been shown that increasing surface nanostructuring via CNT scaffolds has a positive effect on cell viability. Given the enhanced capacitance of such nanostructured electrodes, this result of increased cell viability of hNSCs on CNT-nanostructured BNCD is very promising for improving the performance of electrodes at the brain-machine interface, micro-electrode arrays and in lab-on-chip devices.
